Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Company Profile Biocure Technology Inc C.CURE.X

Alternate Symbol(s):  BICTF

Biocure Technology Inc. is a biopharmaceutical company. The Company specializes in the development and commercialization of its own CAR T-cell therapy, targeting Chronic lymphocytic leukemia and solid tumor cancers. Additionally, the Company is developing biosimilar technologies for cancer treatment. The Company’s products include Interferon Beta, Ranibizumab and PEG-Filgrastim.

Showcase News Releases

Showcase news

Visionstate Corp.
Visionstate Corp. Secures Funding to Enhance AI Capabilities in WANDA Technology through Amii Partnership
Silvercorp Metals Inc.
Silvercorp Announces Filing of Updated Technical Report for the GC Mine
Benton Resources Inc.
Benton Encouraged By Clean Air Metals Latest Drill Results and Advancement Plans; Provides Great Burnt Update and Grants Options

More Showcase News Releases »